Leonel Hernandez-Aya, MD

Sylvester Comprehensive Cancer Center

Asst. Professor of Clinical Medicine

Expertise: Melanoma Cancer Brain Breast Cancer ASCO 2024 Oncology

Sylvester Opens Satellite Office in Naples

Immunotherapy Program Ready to Tackle Cancer Side Effects

No Research/Citations

Phase II multi-center study of adjuvant nivolumab in combination with ipilimumab in patients with high-risk uveal melanoma (HCRN MEL17-309)

29-May-2024 12:05:25 PM EDT

Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy.

29-May-2024 11:05:19 AM EDT

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video

0.07865